UPDATED Apr 22, 2024
Discover large cap French Pharmaceuticals & Biotech companies that are on the CAC. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SAN | €88.17 | 0.8% | -14.2% | €110.1b | €107.50 | PE20.4x | E13.8% | 4.3% | ||
DIM | €200.60 | -21.2% | -23.1% | €19.5b | €257.08 | PE76.6x | E23.3% | 0.3% | ||
ERF | €60.28 | -0.5% | -1.2% | €11.6b | €60.00 | PE45.3x | E19.7% | 0.8% | ||
IPN | €112.50 | 3.8% | 4.9% | €9.3b | €124.63 | PE15.1x | E6.0% | 1.1% | ||
VIRP | €357.00 | -0.8% | 17.8% | €3.0b | €361.56 | PE24.6x | E11.2% | 0.4% | ||
VETO | €97.70 | 0.4% | 12.0% | €1.2b | €108.42 | PE20.8x | E5.0% | 0.9% | ||
ABVX | €14.40 | 3.0% | -7.8% | €906.0m | €35.74 | PS201.7x | E14.6% | n/a | ||
BOI | €33.85 | -1.0% | -13.2% | €587.7m | €39.60 | PE12.3x | E-0.3% | 3.2% | ||
VLA | €3.71 | -7.6% | -21.1% | €514.9m | €8.95 | PS3.3x | E50.9% | n/a | ||
MEDCL | €11.56 | 25.7% | 27.0% | €332.3m | €16.75 | PS23.5x | E68.2% | n/a | ||
EAPI | €2.75 | -0.7% | -74.7% | €260.8m | €4.72 | PB0.3x | E85.2% | n/a | ||
NANO | €5.38 | 0.7% | 51.5% | €253.5m | €11.30 | PS37.6x | E9.5% | n/a | ||
ALSEN | €0.73 | -1.6% | 126.8% | €200.6m | €2.38 | PS36x | E42.8% | n/a | ||
ALCLS | €2.46 | 3.6% | 37.0% | €176.1m | n/a | PS7.7x | E45.9% | n/a | ||
IPH | €2.17 | -4.2% | -20.0% | €175.0m | €6.27 | PS2.8x | E33.0% | n/a | ||
AELIS | €13.10 | 0% | -7.1% | €172.0m | €20.67 | PS13.9x | E-43.4% | n/a | ||
IVA | €3.16 | -5.5% | 30.6% | €164.1m | €13.83 | PS7.1x | E17.6% | n/a | ||
GNFT | €3.24 | -0.2% | -1.5% | €160.8m | €9.38 | PS4.7x | E54.7% | n/a | ||
ALERS | €14.80 | -2.4% | -9.2% | €151.3m | €30.00 | PE31.5x | E36.3% | n/a | ||
TNG | €1.33 | -8.1% | -29.4% | €133.8m | €3.50 | PS16.9x | E-26.1% | n/a | ||
OSE | €5.97 | 29.4% | 37.4% | €128.8m | €7.15 | PS57.8x | E92.9% | n/a | ||
ADOC | €8.68 | -1.6% | 208.9% | €124.0m | €9.70 | PS11.4x | E84.1% | n/a | ||
DBV | €1.21 | -6.5% | -59.9% | €116.4m | €4.78 | PS7.9x | E53.3% | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |